HIV/AIDS Therapy
Cessation of CMV retinitis therapy has no long-term sequelae for HIV patients
Published in AIDS Weekly, May 3rd, 2004
"Potent antiretroviral therapy stimulates robust and durable immune reconstitution among profoundly immunosuppressed patients that is clinically important," according to scientists in the United States.
In a study conducted by P.A. Sklar and coauthors at the National Institutes of Health, "[f]ifteen patients with cytomegalovirus retinitis (CMVR) were followed after discontinuing anti-cytomegalovirus therapy.
"No patient had progression or relapse for a median of 51 months," published data showed. "Survival from the diagnosis of CMVR was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-05-03)
More Articles from AIDS Weekly
- HIV/AIDS Enzymology
E152 amino acid region of HIV integrase characterized - HIV/AIDS Epidemiology
Muslim areas in Africa have lower rates of HIV infection - HIV/AIDS Gene Therapy
Recombinant AAV-2 useful as anti-HIV RNAi vector - HIV/AIDS Therapy
Early IL-2 treatment increases CD4 cell count in HIV patients - HIV/AIDS Therapy
In utero AZT exposure has little or no impact on neurodevelopment - AIDS/HIV Pathogenesis
Antibodies that recognize HIV coreceptor-binding site on gp120 studied - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
